Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase
- PMID: 22185586
- DOI: 10.1021/jm201384j
Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase
Erratum in
-
Correction to Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase.J Med Chem. 2017 Apr 13;60(7):3219. doi: 10.1021/acs.jmedchem.7b00427. Epub 2017 Mar 24. J Med Chem. 2017. PMID: 28339203 No abstract available.
Similar articles
-
Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs.Future Med Chem. 2012 Apr;4(5):625-50. doi: 10.4155/fmc.12.10. Future Med Chem. 2012. PMID: 22458682 Review.
-
Synthesis and antiviral properties of novel tetracyclic nucleoside inhibitors of hepatitis C NS5B polymerase.Nucleosides Nucleotides Nucleic Acids. 2012;31(8):592-607. doi: 10.1080/15257770.2012.707344. Nucleosides Nucleotides Nucleic Acids. 2012. PMID: 22908950
-
Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.Bioorg Med Chem Lett. 2014 Jul 15;24(14):3092-5. doi: 10.1016/j.bmcl.2014.05.015. Epub 2014 May 22. Bioorg Med Chem Lett. 2014. PMID: 24907145
-
Current perspective of HCV NS5B inhibitors: a review.Curr Med Chem. 2011;18(36):5564-97. doi: 10.2174/092986711798347234. Curr Med Chem. 2011. PMID: 22172066 Review.
-
Nucleoside analog inhibitors of hepatitis C virus replication.Infect Disord Drug Targets. 2006 Mar;6(1):17-29. doi: 10.2174/187152606776056698. Infect Disord Drug Targets. 2006. PMID: 16787301 Review.
Cited by
-
Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors.Bioorg Med Chem. 2023 Feb 15;80:117179. doi: 10.1016/j.bmc.2023.117179. Epub 2023 Jan 21. Bioorg Med Chem. 2023. PMID: 36716583 Free PMC article.
-
Diastereoselective Synthesis of 2'-Dihalopyrimidine Ribonucleoside Inhibitors of Hepatitis C Virus Replication.ACS Omega. 2021 Dec 22;7(1):1452-1461. doi: 10.1021/acsomega.1c06174. eCollection 2022 Jan 11. ACS Omega. 2021. PMID: 35036807 Free PMC article.
-
In silico prediction of SARS-CoV-2 main protease and polymerase inhibitors: 3D-Pharmacophore modelling.J Biomol Struct Dyn. 2022 Sep;40(14):6569-6586. doi: 10.1080/07391102.2021.1886991. Epub 2021 Feb 18. J Biomol Struct Dyn. 2022. PMID: 33599180 Free PMC article.
-
ATP Is an Allosteric Inhibitor of Coxsackievirus B3 Polymerase.Biochemistry. 2016 Jul 19;55(28):3995-4002. doi: 10.1021/acs.biochem.6b00467. Epub 2016 Jul 6. Biochemistry. 2016. PMID: 27319576 Free PMC article.
-
A power law function describes the time- and dose-dependency of Vγ9Vδ2 T cell activation by phosphoantigens.Biochem Pharmacol. 2018 Dec;158:298-304. doi: 10.1016/j.bcp.2018.10.035. Epub 2018 Nov 2. Biochem Pharmacol. 2018. PMID: 30391478 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical